Paris, February 21st, 2018 – iBionext Growth Fund, an investment fund dedicated to building, supporting and financing the innovative companies of the iBionext start-up studio, today announced the strengthening of its stake in Prophesee (formerly Chronocam), a year after its…
“iBionext a finalisé, à 90 M€, le closing de son premier fonds, iBionext Growth Fund. Ces moyens vont lui permettre d’accompagner les sociétés de son portefeuille dans la « Vallée de la mort », entre l’amorçage et le développement late…
Le fonds iBionext dédié aux healthtechs https://www.radioclassique.fr/radio/emissions/matinale-de-radio-classique/confidentiels-business-de-capital-finance/
https://labiotech.eu/ibionext-growth-fund-bpifrance/ iBionext has closed its Growth Fund, which has raised money from investors like Bpifrance to help young biotechs to reach their potential. iBionext is a French ‘startup studio’ that specializes in the creation and development of startups in the healthcare industry….
http://www.lefigaro.fr/flash-eco/2018/02/14/97002-20180214FILWWW00183-ibionext-leve-un-fonds-de-90m-pour-la-sante.php Ibionext lève un fonds de 90M€ pour la santé La société parisienne Ibionext, spécialisée dans l’incubation et la gestion de start-ups innovantes dans les sciences de la vie, a annoncé mercredi avoir finalisé la levée d’un nouveau fonds de…
https://capitalfinance.lesechos.fr/fonds/levees/sciences-de-la-vie-ibionext-growth-fund-dispose-de-90-m-117863 Sciences de la vie : iBionext Growth Fund dispose de 90 M€ La structure dirigée par Bernard Gilly et Alexia Pérouse a choisi de limiter les interventions de ce véhicule à six start-up. iBionext officialise le closing final de…
http://www.boursorama.com/actualites/le-journal-des-biotechs-poxel-adocia-lysogene-et-l-interview-d-alexia-perouse-d-ibionext-20d6c41f514b0ca4ded482f6bb0e1601
Dedicated to the creation and development of disruptive healthcare start-ups Paris, February 14th 2018 – iBionext, a management company and start-up studio specializing in the creation and development of disruptive healthcare start-ups, today announced that it has completed the closing…
